Related Experiment Video

Updated: Sep 25, 2025

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

4.0K

Guideline directed medical therapy and reduction of secondary mitral regurgitation

Georg Spinka1, Philipp E Bartko1, Gregor Heitzinger1

  • 1Department of Internal Medicine II, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria.

European Heart Journal. Cardiovascular Imaging
|April 25, 2022
PubMed

Insights

Guideline-directed medical therapy (GDMT) effectively reduces secondary mitral regurgitation (SMR) severity. Titrating GDMT, including specific drug combinations, significantly increases the likelihood of SMR improvement and reverse remodeling.

Area of Science:

  • Cardiology
  • Pharmacology
  • Medical Therapy

Background:

  • Secondary mitral regurgitation (SMR) treatment lacks comprehensive evidence for guideline-directed medical therapy (GDMT).
  • Assessing GDMT titration's impact on SMR is crucial for clinical practice.
  • Identifying specific pharmacologic combinations for SMR reduction is needed.

Purpose of the Study:

  • To evaluate the effectiveness of GDMT titration in improving SMR.
  • To identify specific drug combinations within GDMT that reduce SMR severity.
  • To provide evidence supporting GDMT for SMR management.

Main Methods:

  • Retrospective analysis of 261 patients with serial echocardiograms.
  • Logistic regression to assess GDMT titration and specific substance effects on SMR.
  • Defined GDMT titration and SMR reduction criteria.

Main Results:

  • GDMT titration was associated with a significant increase in SMR severity improvement (adj. OR 2.91).
  • 39.3% of patients experienced at least a 1° SMR improvement after GDMT titration.
  • Angiotensin receptor/neprilysin inhibitors (ARNi), and combinations of RASi/MRA, BB/MRA, and RASi/BB/MRA showed significant SMR improvement.

Conclusions:

  • GDMT titration significantly enhances the chance of reducing SMR severity.
  • Specific pharmacologic combinations, including ARNi and multi-drug regimens (RASi, MRA, BB), are effective in improving SMR.
  • This study provides robust evidence for using contemporary GDMT to manage SMR.
Abstract

Keywords:
compound sequencing algorithmdosage effectguideline-directed medical therapysecondary mitral regurgitationtitration

More Related Videos

An Image Guided Transapical Mitral Valve Leaflet Puncture Model of Controlled Volume Overload from Mitral Regurgitation in the Rat07:42

An Image Guided Transapical Mitral Valve Leaflet Puncture Model of Controlled Volume Overload from Mitral Regurgitation in the Rat

Published on: May 19, 2020

7.2K
Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

1.8K

Related Concept Videos

Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
38
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
31
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
105
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
42
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
49
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
56